510 related articles for article (PubMed ID: 2112515)
21. HLA antigen expression and malignant mesothelioma.
Christmas TI; Manning LS; Davis MR; Robinson BW; Garlepp MJ
Am J Respir Cell Mol Biol; 1991 Sep; 5(3):213-20. PubMed ID: 1910807
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon.
Abril E; Mendez RE; García A; Serrano A; Cabrera T; Garrido F; Ruiz-Cabello F
Tissue Antigens; 1996 May; 47(5):391-8. PubMed ID: 8795139
[TBL] [Abstract][Full Text] [Related]
23. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
[TBL] [Abstract][Full Text] [Related]
24. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order.
Erlich H; Lee JS; Petersen JW; Bugawan T; DeMars R
Hum Immunol; 1986 Jun; 16(2):205-19. PubMed ID: 3459724
[TBL] [Abstract][Full Text] [Related]
26. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
27. Differential enhancement of interferon-gamma-induced MHC class II expression of HEp-2 cells by 1,25-dihydroxyvitamin D3.
Tamaki K; Nakamura K
Br J Dermatol; 1990 Sep; 123(3):333-8. PubMed ID: 2119787
[TBL] [Abstract][Full Text] [Related]
28. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
[TBL] [Abstract][Full Text] [Related]
29. Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.
Schwartz R; Momburg F; Moldenhauer G; Dörken B; Schirrmacher V
Int J Cancer; 1985 Feb; 35(2):245-50. PubMed ID: 3918946
[TBL] [Abstract][Full Text] [Related]
30. Modulation of proliferation, estradiol receptors and estrogen regulated protein PS2/BCEI in human breast cancer cell lines by gamma interferon.
Solary E; Prud'homme JF; Gauville C; Magdelenat H; Calvo F
J Biol Regul Homeost Agents; 1991; 5(3):98-106. PubMed ID: 1763658
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
32. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines.
Sugimoto T; Horii Y; Hino T; Kemshead JT; Kuroda H; Sawada T; Morioka H; Imanishi J; Inoko H
Cancer Res; 1989 Apr; 49(7):1824-8. PubMed ID: 2493986
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of MHC-class-I alterations in human tumor cell lines.
Ruiz-Cabello F; Perez-Ayala M; Gomez O; Redondo M; Concha A; Cabrera T; Garrido F
Int J Cancer Suppl; 1991; 6():123-30. PubMed ID: 1906050
[TBL] [Abstract][Full Text] [Related]
34. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E
Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of HLA-class II antigen mRNAs on T lymphoblasts].
Tate G; Katagiri M
Hokkaido Igaku Zasshi; 1986 Mar; 61(2):249-56. PubMed ID: 3487495
[TBL] [Abstract][Full Text] [Related]
36. Pattern of expression of HLA-DR and HLA-DQ antigens and mRNA in myeloid differentiation.
Amatruda TT; Bohman R; Ranyard J; Koeffler HP
Blood; 1987 Apr; 69(4):1225-36. PubMed ID: 3103718
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of ovine alveolar macrophages: regulation of surface antigen expression and cytokine production.
Nash AD; Barcham GJ; Andrews AE; Brandon MR
Vet Immunol Immunopathol; 1992 Feb; 31(1-2):77-94. PubMed ID: 1570684
[TBL] [Abstract][Full Text] [Related]
38. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
39. Regulation of major histocompatibility gene expression in human vascular smooth muscle cells.
Warner SJ; Friedman GB; Libby P
Arteriosclerosis; 1989; 9(3):279-88. PubMed ID: 2470342
[TBL] [Abstract][Full Text] [Related]
40. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
